Can difficult-to-reuse syringes reduce the spread of HIV among injection drug users?
ResearchPublished 1998
ResearchPublished 1998
Sharing of syringes by injection drug users is a principal means by which the human immunodeficiency virus (HIV) is spread. Some have suggested that distributing syringes that are difficult to reuse (DTR) would slow the spread of HIV. The authors developed a simple mathematical model that describes how changes in the numbers of DTR syringes or regular syringes consumed over the course of a fixed number of injections affect the proportion of injections that are potentially infectious and, thus, the transmission of HIV. It suggests that increasing consumption of either type of syringe will reduce the proportion of potentially infectious injections, but that, per syringe added, the reduction is always greater if a regular rather than a DTR syringe is added. Similarly, introducing a certain number of DTR syringes and simultaneously reducing the consumption of regular syringes by the same number will increase, not decrease, the proportion of infectious injections. DTR syringes are more expensive than regular syringes, so there is little justification for substituting them for regular syringes.
Originally published in: Interfaces, v. 28, no. 3, May-June 1998, pp. 23-33.
This publication is part of the RAND reprint series. The reprint series, a product of RAND from 1992 to 2011, included previously published journal articles, book chapters, and reports that were reproduced by RAND with the permission of the publisher. RAND reprints were formally reviewed in accordance with the publisher's editorial policy and compliant with RAND's rigorous quality assurance standards for quality and objectivity. For select current RAND journal articles, see external publications.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.